These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36829723)

  • 1. rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing.
    Iglesias CF; Ristovski M; Bolic M; Cuperlovic-Culf M
    Bioengineering (Basel); 2023 Feb; 10(2):. PubMed ID: 36829723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The state of technological advancement to address challenges in the manufacture of rAAV gene therapies.
    Destro F; Wu W; Srinivasan P; Joseph J; Bal V; Neufeld C; Wolfrum JM; Manalis SR; Sinskey AJ; Springs SL; Barone PW; Braatz RD
    Biotechnol Adv; 2024 Nov; 76():108433. PubMed ID: 39168354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the Development of Soft Sensors for Bioprocesses: A Critical Review.
    Brunner V; Siegl M; Geier D; Becker T
    Front Bioeng Biotechnol; 2021; 9():722202. PubMed ID: 34490228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector system.
    Destro F; Joseph J; Srinivasan P; Kanter JM; Neufeld C; Wolfrum JM; Barone PW; Springs SL; Sinskey AJ; Cecchini S; Kotin RM; Braatz RD
    Mol Ther Methods Clin Dev; 2023 Sep; 30():122-146. PubMed ID: 37746245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies.
    Gimpel AL; Katsikis G; Sha S; Maloney AJ; Hong MS; Nguyen TNT; Wolfrum J; Springs SL; Sinskey AJ; Manalis SR; Barone PW; Braatz RD
    Mol Ther Methods Clin Dev; 2021 Mar; 20():740-754. PubMed ID: 33738328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular pathways of recombinant adeno-associated virus production for gene therapy.
    Sha S; Maloney AJ; Katsikis G; Nguyen TNT; Neufeld C; Wolfrum J; Barone PW; Springs SL; Manalis SR; Sinskey AJ; Braatz RD
    Biotechnol Adv; 2021; 49():107764. PubMed ID: 33957276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in upstream process development for production of recombinant adeno-associated virus.
    Ou J; Tang Y; Xu J; Tucci J; Borys MC; Khetan A
    Biotechnol Bioeng; 2024 Jan; 121(1):53-70. PubMed ID: 37691172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.
    Adamson-Small L; Potter M; Byrne BJ; Clément N
    Hum Gene Ther Methods; 2017 Feb; 28(1):1-14. PubMed ID: 28117600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design space determination to optimize DNA complexation and full capsid formation in transient rAAV manufacturing.
    Fu Q; Lee YS; Green EA; Wang Y; Park SY; Polanco A; Lee KH; Betenbaugh M; McNally D; Yoon S
    Biotechnol Bioeng; 2023 Nov; 120(11):3148-3162. PubMed ID: 37475681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rAAV2-producing yeast screening model to identify host proteins enhancing rAAV DNA replication and vector yield.
    Aponte-Ubillus JJ; Barajas D; Peltier J; Bardliving C; Shamlou P; Gold D
    Biotechnol Prog; 2019 Jan; 35(1):e2725. PubMed ID: 30298993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach.
    Zhao H; Lee KJ; Daris M; Lin Y; Wolfe T; Sheng J; Plewa C; Wang S; Meisen WH
    Mol Ther Methods Clin Dev; 2020 Sep; 18():312-320. PubMed ID: 32671134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving adeno-associated vector yield in high density insect cell cultures.
    Mena JA; Aucoin MG; Montes J; Chahal PS; Kamen AA
    J Gene Med; 2010 Feb; 12(2):157-67. PubMed ID: 20101623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging rAAV bioprocess understanding and next generation bioanalytics development.
    Escandell JM; Pais DA; Carvalho SB; Vincent K; Gomes-Alves P; Alves PM
    Curr Opin Biotechnol; 2022 Apr; 74():271-277. PubMed ID: 35007989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences.
    Shi S; Mercer SA; Dilley R; Trippel SB
    Virol J; 2009 Jan; 6():3. PubMed ID: 19128486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus perfusion enhanced expression: A commercially scalable, high titer, high quality producer cell line process.
    Xue W; Fulco C; Sha S; Alden N; Panteli J; Hossler P; Warren J
    Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101266. PubMed ID: 38868441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.